Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Jan 23, 2024 $26.67 $27.13 $26.18 $26.71 659 873
Jan 22, 2024 $26.05 $26.53 $25.97 $26.27 828 676
Jan 19, 2024 $26.24 $26.55 $25.96 $26.01 586 673
Jan 18, 2024 $26.96 $27.13 $26.00 $26.02 769 988
Jan 17, 2024 $26.00 $27.07 $25.94 $26.95 990 591
Jan 16, 2024 $26.26 $26.51 $25.54 $26.40 640 118
Jan 12, 2024 $27.41 $28.26 $26.18 $26.55 1 121 856
Jan 11, 2024 $25.01 $27.15 $24.82 $26.89 1 451 340
Jan 10, 2024 $26.33 $26.68 $24.96 $25.40 1 321 848
Jan 09, 2024 $25.04 $26.94 $24.99 $26.37 2 478 367
Jan 08, 2024 $21.23 $25.12 $21.05 $25.10 1 366 470
Jan 05, 2024 $21.00 $21.48 $20.68 $21.47 587 805
Jan 04, 2024 $21.67 $21.77 $20.95 $21.13 677 488
Jan 03, 2024 $22.32 $22.39 $21.61 $21.67 662 927
Jan 02, 2024 $21.35 $22.85 $21.35 $22.48 690 942
Dec 29, 2023 $22.08 $22.08 $21.64 $21.67 490 747
Dec 28, 2023 $22.30 $22.75 $21.80 $22.06 602 195
Dec 27, 2023 $22.25 $22.31 $21.84 $22.26 456 701
Dec 26, 2023 $22.07 $22.40 $21.90 $22.17 480 004
Dec 22, 2023 $21.75 $22.43 $21.49 $21.85 607 056
Dec 21, 2023 $21.16 $21.69 $21.08 $21.47 563 566
Dec 20, 2023 $22.01 $22.07 $20.83 $20.88 763 402
Dec 19, 2023 $21.46 $22.24 $21.15 $22.22 670 106
Dec 18, 2023 $21.56 $21.63 $21.03 $21.15 666 325
Dec 15, 2023 $21.51 $21.98 $21.20 $21.66 2 417 569
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT